Atinum Investment Co., Ltd (KOSDAQ:021080)
South Korea · Delayed Price · Currency is KRW 3,370.00
-60.00 (-1.75%)
At close: Apr 30, 2026
Atinum Investment Market Cap
Atinum Investment has a market cap or net worth of 161.19 billion as of April 30, 2026. Its market cap has increased by 61.41% in one year.
Market Cap
161.19B
Enterprise Value
n/a
Revenue
8.92B
Ranking
n/a
PE Ratio
51.16
Stock Price
3,370.00
Market Cap Chart
Since January 22, 2001, Atinum Investment's market cap has increased from 34.86B to 161.19B, an increase of 362.40%. That is a compound annual growth rate of 6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 158.37B | 17.42% |
| Dec 30, 2025 | 134.87B | 32.87% |
| Dec 30, 2024 | 101.51B | -39.75% |
| Dec 28, 2023 | 168.48B | 36.83% |
| Dec 29, 2022 | 123.13B | -51.69% |
| Dec 30, 2021 | 254.88B | 104.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wonik Pne | 170.68B |
| NewFlex Technology | 170.42B |
| Multicampus | 170.39B |
| Daihan Pharmaceutical | 170.23B |
| LiComm | 170.19B |
| TOPTEC | 169.43B |
| OPTUS Pharmaceutical | 169.41B |
| Keeps Biopharma | 169.26B |